CSL Behring Gets FDA Approval to Extend Privigen Shelf Life

CSL Behring, a subsidiary of CSL Limited, announced that the U.S. Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life for Privigen, Immune Globulin Intravenous (Human), 10% Liquid, from 24 to 36 months.
RTT News